Manufacturer record
Reon Pharma: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Reon Pharma (Gujarat) were declared Not of Standard Quality between December 2023 and December 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
2 records linked to Reon Pharma in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Cefuroxime Axetil Tablets IP (Roxim- 500 Tablets) | 457783Mfg 2023-03 · Exp 2026-02 | Identification, Uniformity of weight and Assay of Cefuroxime Axetil eq. to CefuroximeAssay | RDTL ChandigarhState lab | Dec 2023 |
| Azithromycin Tablets IP 500 mg (Zathron-500 Tablets) | 45865Mfg 2023-03 · Exp 2025-02 | Identification and Assay of Azithromycin Dihydrate equivalent to anhydrous AzithromycinAssay | RDTL ChandigarhState lab | Dec 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.